Introduction Medications for opioid use disorder (MOUD) are evidence-based treatments, yet
can be controversial among some populations. This study provides a systematic review of …

During the current coronavirus disease 2019 epidemic, many outpatient chemical
dependency treatment programs and clinics are decreasing their number of in-person …

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

Amid worsening opioid overdose death rates, the nation continues to face a persistent
addiction treatment gap limiting access to quality care for opioid use disorder (OUD). Three …

Importance Opioid overdose deaths in the United States continue to increase, reflecting a
growing need to treat those with opioid use disorder (OUD). Little is known about counties …

Background and Objectives The opioid crisis has taken an immense toll in the United States.
On average, five lives are lost to an opioid overdose every hour of the day; estimated costs …

Long acting injectable formulations have been developed to sustain the action of drugs in
the body over desired periods of time. These delivery platforms have been utilized for both …

Given the high prevalence of individuals diagnosed with substance use disorder, along with
the elevated rate of relapse following treatment initiation, investigating novel approaches …

Background Maintenance treatments with medications for opioid use disorder (MOUD) are
highly effective at reducing overdose risk while patients remain in care. However, few …

With the aging population, an increasing number of older adults (> 65 years) will be affected
by problematic opioid use and opioid use disorder (OUD), with both illicit and prescription …